• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proficiency testing for SARS-CoV-2 whole genome sequencing.SARS-CoV-2 全基因组测序能力验证。
Pathology. 2022 Aug;54(5):615-622. doi: 10.1016/j.pathol.2022.04.002. Epub 2022 Jun 29.
2
Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program.SARS-CoV-2 全基因组测序能力验证计划的持续改进。
Pathology. 2024 Aug;56(5):717-725. doi: 10.1016/j.pathol.2024.02.010. Epub 2024 Apr 24.
3
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories.细菌全基因组测序能力验证确保临床和公共卫生实验室微生物诊断质量
Pathology. 2021 Dec;53(7):902-911. doi: 10.1016/j.pathol.2021.03.012. Epub 2021 Jul 15.
4
Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.新冠病毒 S 基因序列数据的生物信息学研究:大流行监测期间稳健基因组分析的启示。
Microb Genom. 2023 Nov;9(11). doi: 10.1099/mgen.0.001146.
5
Whole-genome sequencing for antimicrobial surveillance: species-specific quality thresholds and data evaluation from the network of the European Union Reference Laboratory for Antimicrobial Resistance genomic proficiency tests of 2021 and 2022.全基因组测序用于抗菌药物监测:来自 2021 年和 2022 年欧盟抗菌药物耐药参考实验室基因组能力测试网络的针对特定物种的质量阈值和数据评估。
mSystems. 2024 Sep 17;9(9):e0016024. doi: 10.1128/msystems.00160-24. Epub 2024 Aug 6.
6
Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.用于 SARS-CoV-2 监测生物信息学的基准数据集。
PeerJ. 2022 Sep 5;10:e13821. doi: 10.7717/peerj.13821. eCollection 2022.
7
Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories.用于保证临床和公共卫生实验室病毒 RNA 检测质量和整体性能的 SARS-CoV-2 能力验证。
Pathology. 2022 Jun;54(4):472-478. doi: 10.1016/j.pathol.2022.01.006. Epub 2022 Apr 16.
8
An implementation science approach to evaluating pathogen whole genome sequencing in public health.公共卫生中应用病原全基因组测序的实施科学方法评估。
Genome Med. 2021 Jul 28;13(1):121. doi: 10.1186/s13073-021-00934-7.
9
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.纳米孔测序快速分析 SARS-CoV-2 基因组的分析有效性。
Nat Commun. 2020 Dec 9;11(1):6272. doi: 10.1038/s41467-020-20075-6.
10
Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet.公共卫生实验室中的病原体基因组学:来自加利福尼亚 SARS-CoV-2 全基因组测序计划(加利福尼亚 COVIDNet)的成功经验、挑战和教训。
Microb Genom. 2023 Jun;9(6). doi: 10.1099/mgen.0.001027.

引用本文的文献

1
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development.严重急性呼吸综合征冠状病毒2的进化:对诊断、治疗、疫苗有效性及研发的影响
Vaccines (Basel). 2024 Dec 28;13(1):17. doi: 10.3390/vaccines13010017.
2
Virus sequencing performance during the SARS-CoV-2 pandemic: a retrospective analysis of data from multiple rounds of external quality assessment in Austria.新冠疫情期间的病毒测序表现:奥地利多轮外部质量评估数据的回顾性分析
Front Mol Biosci. 2024 Feb 5;11:1327699. doi: 10.3389/fmolb.2024.1327699. eCollection 2024.
3
Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.

本文引用的文献

1
AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic.澳塔克:为应对新冠疫情,加速实现基因组学监测的国有化。
Nat Commun. 2022 Feb 14;13(1):865. doi: 10.1038/s41467-022-28529-9.
2
Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool.使用穿山甲工具对新出现的大流行中的流行病学谱系进行分类。
Virus Evol. 2021 Jul 30;7(2):veab064. doi: 10.1093/ve/veab064. eCollection 2021.
3
A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples.
新冠病毒 S 基因序列数据的生物信息学研究:大流行监测期间稳健基因组分析的启示。
Microb Genom. 2023 Nov;9(11). doi: 10.1099/mgen.0.001146.
一项使用新冠患者样本对新冠病毒全基因组测序方案进行的基准研究。
iScience. 2021 Aug 20;24(8):102892. doi: 10.1016/j.isci.2021.102892. Epub 2021 Jul 21.
4
Surveillance for SARS-CoV-2 variants of concern in the Australian context.澳大利亚对关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的监测。
Med J Aust. 2021 Jun;214(11):500-502.e1. doi: 10.5694/mja2.51105. Epub 2021 May 31.
5
Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.全基因组测序揭示了 SARS-CoV-2 在巴基斯坦的 G614 变异株检测。
PLoS One. 2021 Mar 23;16(3):e0248371. doi: 10.1371/journal.pone.0248371. eCollection 2021.
6
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions.SARS-CoV-2 感染的 shotgun 转录组、空间组学和等温分析揭示了独特的宿主反应、病毒多样化和药物相互作用。
Nat Commun. 2021 Mar 12;12(1):1660. doi: 10.1038/s41467-021-21361-7.
7
Clinical and whole genome characterization of SARS-CoV-2 in India.印度 SARS-CoV-2 的临床和全基因组特征。
PLoS One. 2021 Feb 2;16(2):e0246173. doi: 10.1371/journal.pone.0246173. eCollection 2021.
8
Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100 System.通过比较MinION和Illumina iSeq100系统基于直接扩增子测序的SARS-CoV-2快速基因组特征分析
Front Microbiol. 2020 Sep 25;11:571328. doi: 10.3389/fmicb.2020.571328. eCollection 2020.
9
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region.测序确定了 SARS-CoV-2 多次早期传入纽约地区。
Genome Res. 2020 Dec;30(12):1781-1788. doi: 10.1101/gr.266676.120. Epub 2020 Oct 22.
10
Cryptic transmission of SARS-CoV-2 in Washington state.华盛顿州出现的 SARS-CoV-2 隐匿传播。
Science. 2020 Oct 30;370(6516):571-575. doi: 10.1126/science.abc0523. Epub 2020 Sep 10.

SARS-CoV-2 全基因组测序能力验证。

Proficiency testing for SARS-CoV-2 whole genome sequencing.

机构信息

RCPAQAP Biosecurity, St Leonards, NSW, Australia.

Communicable Diseases Genomics Network (CDGN), Public Health Laboratory Network (PHLN), Sydney, NSW, Australia; Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), The University of Melbourne at The Peter Doherty Institute for Immunity and Infection, Melbourne, Vic, Australia.

出版信息

Pathology. 2022 Aug;54(5):615-622. doi: 10.1016/j.pathol.2022.04.002. Epub 2022 Jun 29.

DOI:10.1016/j.pathol.2022.04.002
PMID:35778290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9239710/
Abstract

Extensive studies and analyses into the molecular features of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) have enhanced the surveillance and investigation of its clusters and transmission worldwide. The whole genome sequencing (WGS) approach is crucial in identifying the source of infection and transmission routes by monitoring the emergence of variants over time and through communities. Varying SARS-CoV-2 genomics capacity and capability levels have been established in public health laboratories across different Australian states and territories. Therefore, laboratories performing SARS-CoV-2 WGS for public health purposes are recommended to participate in an external proficiency testing program (PTP). This study describes the development of a SARS-CoV-2 WGS PTP. The PTP assessed the performance of laboratories while providing valuable insight into the current state of SARS-CoV-2 genomics in public health across Australia. Part 1 of the PTP contained eight simulated SARS-CoV-2 positive and negative specimens to assess laboratories' wet and dry laboratory capacity. Part 2 involved the analysis of a genomic dataset that consisted of a multi-FASTA file of 70 consensus genomes of SARS-CoV-2. Participating laboratories were required to (1) submit raw data for independent bioinformatics analysis, (2) analyse the data with their processes, and (3) answer relevant questions about the data. The performance of the laboratories was commendable, despite some variation in the reported results due to the different sequencing and bioinformatics approaches used by laboratories. The overall outcome is positive and demonstrates the critical role of the PTP in supporting the implementation and validation of SARS-CoV-2 WGS processes. The data derived from this PTP will contribute to the development of SARS-CoV-2 bioinformatic quality control (QC) and performance benchmarking for accreditation.

摘要

对严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)的分子特征进行了广泛的研究和分析,增强了对其在全球范围内的聚类和传播的监测和调查。全基因组测序(WGS)方法通过监测随时间和通过社区出现的变体,对于识别感染源和传播途径至关重要。不同的澳大利亚州和地区的公共卫生实验室已经建立了不同的 SARS-CoV-2 基因组学能力和能力水平。因此,建议从事公共卫生目的 SARS-CoV-2 WGS 的实验室参加外部能力验证测试计划(PTP)。本研究描述了 SARS-CoV-2 WGS PTP 的开发。该 PTP 评估了实验室的性能,同时提供了有关澳大利亚公共卫生领域 SARS-CoV-2 基因组学现状的宝贵见解。PTP 的第 1 部分包含 8 个模拟 SARS-CoV-2 阳性和阴性样本,以评估实验室的湿实验室和干实验室能力。第 2 部分涉及分析基因组数据集,该数据集由 70 个 SARS-CoV-2 共识基因组的多 FASTA 文件组成。要求参与实验室(1)提交原始数据进行独立的生物信息学分析,(2)用其流程分析数据,以及(3)回答有关数据的相关问题。尽管由于实验室使用的不同测序和生物信息学方法导致报告结果存在差异,但实验室的表现值得称赞。总体结果是积极的,证明了 PTP 在支持 SARS-CoV-2 WGS 流程的实施和验证方面的关键作用。该 PTP 产生的数据将有助于 SARS-CoV-2 生物信息学质量控制(QC)和认证性能基准的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/18eedbc3bba4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/143f20074a2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/0f24126c7e6f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/25865f3a0c0a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/18eedbc3bba4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/143f20074a2d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/0f24126c7e6f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/25865f3a0c0a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/746b/9239710/18eedbc3bba4/gr4_lrg.jpg